Paid Clinical Trials in Alabama
Alabama has 1,359 paid clinical trials enrolling now across cities including Birmingham, Mobile and Huntsville. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Alabama include University of Alabama at Birmingham, National Cancer Institute (NCI) and AstraZeneca, running studies across oncology, cardiology, neurology, and more. The most actively recruiting conditions are Breast Cancer, Heart Failure, Obesity, Hypertension — browse the full list or use the filters to match your diagnosis. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1,359 clinical trials
↓ Download CSVParathyroid Allotransplantation in Medically Refractory Hypoparathyroidism
Efficacy of Different Disinfection Technologies in Molar Non-Surgical Retreatment
Comparative Effectiveness in the Management of Irreversible Pulpitis
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
Monitoring Blood Pressure at Home and Pharmacy Telehealth
Feasibility and Acceptability of Three Component Intervention for the Heart Failure Care for Rural Dwelling Participants
Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose
Cue-Based Vs. Clinician-Driven Feeding in Very Low Birthweight Infants
Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis
VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilities
Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix
Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis
The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament Reconstruction
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
A Bundled Intervention to End Opioid Overdoses
Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
Low-Dose Naltrexone For ME/CFS: Dose-Finding
Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Alabama
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
False Vocal Fold vs EMG Guided Botox for Vocal Tremor
Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Brief Single-Session Body Neutrality Program for LGBTQ+ Adults in Central Alabama
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
Ventilator Pressure and Optimization of Compliance and Hemodynamics
Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma
TearCare in Young Adults
Early Time-Restricted Eating for Cardiovascular Health
Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
Abdominal aBscess Catheter Sclerotherapy (ABCS)
Evaluating Avive+ Soft Tissue Matrix for Prevention of Superficial Radial Nerve Morbidity Following Radial Forearm Free Flap Harvest
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Application to Predict Neonatal Apnea With Bradycardia
About research studies in Alabama
Alabama has approximately 1,359 recruiting research studies across a wide range of therapeutic areas. Alabama hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Common conditions studied in Alabama
- Breast Cancer (22 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Heart Failure (21 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Obesity (20 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Hypertension (15 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Multiple Myeloma (15 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Sickle Cell Disease (14 active studies). Sickle cell disease studies test gene therapies, gene editing, and new small molecules aimed at reducing pain crises and organ damage.
Leading research sponsors in Alabama
- University of Alabama at Birmingham
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Local regulations and guidelines
Clinical trials in Alabama are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Alabama research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Alabama. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Alabama
Hipa.ai aggregates every recruiting study in Alabama from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Alabama?
There are approximately 1,359 recruiting clinical trials in Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Alabama pay participants?
Most recruiting trials in Alabama compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Alabama?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Alabama?
The most common conditions under active study in Alabama include Breast Cancer (22), Heart Failure (21), Obesity (20), Hypertension (15), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Alabama?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Alabama on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Alabama?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.